Top Health Tech Companies in Melbourne (62)
For more than two decades, Imprivata has been redefining how life- and mission-critical industries secure and manage digital identities. We empower healthcare and enterprise organizations to enable fast, compliant, and secure access to technology—allowing clinicians and staff to stay focused on what matters most: patient care and operational excellence. Our digital identity platform is purpose-built for complex environments where every second...
Imprivata's Top Stability & Growth Strengths
Strong Revenue Growth: Recurring revenue and contract billings have been rising at low-teen rates since 2022, with expectations for continued double-digit top-line expansion. Reporting also indicates meaningful revenue scale with rapid momentum.
Healthy Cash Flow: Financial analysis points to improving cash generation, with free cash flow expected to increase materially over the near term. This trend signals growing operating efficiency alongside revenue expansion.
Customer Loyalty & Retention: Gross retention remains very high and net revenue retention is described as strong, indicating renewals plus expansion within the existing base. These metrics point to a sticky customer franchise supportive of durable growth.
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Strong Hiring & Retention: Employee headcount is increasing over the 2023–2026 period, indicating ongoing hiring momentum. Feedback suggests workforce expansion is sustained even if the pace has moderated recently.
Market Expansion: A new Jakarta office was opened in 2026 to deepen engagement across Southeast Asia. Operations span dozens of offices in many countries, supporting customers in more than 80 countries.
Innovation-Driven Growth: New offerings such as the Data Studio AI Assistant and continued development of healthcare interoperability products point to active product investment. Feedback suggests AI and healthcare enhancements are a current strategic focus.
Montu is Australia's leading health tech business revolutionising the alternative health landscape. Montu has built an integrated ecosystem, which streamlines the experience for patients end-to-end, and sets new standards. The company is committed to improve the lives of millions of patients
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to...
Moderna's Top Stability & Growth Strengths
Innovation-Driven Growth: The company is positioned as a leader in mRNA medicine with multiple late-stage respiratory and oncology programs that could expand beyond COVID into new indications. Acceptance of the flu BLA and positive Phase 3 data for a flu+COVID combo create concrete approval catalysts that could broaden the seasonal franchise if reviews are favorable.
Product Line Growth: The business is transitioning from a single declining product toward a multi-product portfolio, with RSV, next-gen COVID, flu, and combo vaccines advancing toward targeted 2026 approvals. Management’s expectation of modest revenue growth in 2026, with no flu or flu/COVID revenue assumed, implies potential upside if launches land on time.
Strong Market Position & Advantage: The company has demonstrated platform leadership by scaling mRNA globally during COVID and securing a non-COVID mRNA vaccine approval with mRESVIA, including a label expansion to certain higher-risk adults. Settlement of the lipid-nanoparticle patent dispute removes a major legal overhang, improving focus and visibility for launches and late-stage execution.
Integral Diagnostics is a leading provider of medical imaging services across Australia and New Zealand, offering a comprehensive range of diagnostic modalities including MRI, CT, X-ray, and ultrasound.
Healthcare Australia (HCA) is Australia’s largest diversified healthcare provider, operating nationwide across all sectors of health including primary health care, and acute care. We connect healthcare professionals, organisations, and people to provide end-to-end healthcare solutions. By filling the healthcare skills gap, we ensure Australians always have the support they need—making us Australia's #1 healthcare solutions provider. We're highly experienced: With over 50...
_0.png)
AlayaCare offers an end-to-end, cloud based platform for home and community-based care agencies and organizations to manage the entire client lifecycle from referrals and intake to billing, payroll, optimized visit scheduling, secure data analytics, and beyond. Combining traditional in-home and virtual care solutions, AlayaCare removes repetitive tasks, enabling care providers across the world to propel towards innovation and homecare of...
Epworth HealthCare is Victoria's largest not-for-profit private hospital group, renowned for excellence in diagnosis, treatment, care, and rehabilitation. It operates as a chain of multi-specialty hospitals, embracing evidence-based medicine to pioneer treatments and services for its patients across Melbourne and Geelong.
Profound Change Requires Boldness. Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the...
Johnson & Johnson's Top Stability & Growth Strengths
Strong Revenue Growth: Companywide sales are described as increasing year over year, with momentum exiting 2025 and guidance calling for continued expansion into 2026.
Innovation-Driven Growth: Growth is attributed to innovative medicines and new product submissions, with oncology and immunology performance highlighted as key contributors.
Diversified Revenue Streams: The business is positioned around two large segments—Innovative Medicine and MedTech—creating a broader platform that helps offset declines in specific products.
Mable is a health-tech platform where people looking for disability and aged care support connect with independent support workers in their community. As one of Australia’s fastest-growing scale-ups, we think big to spearhead change in our sector. We're passionate about inclusivity and giving choice and control back to those who need it. Mable launched in 2014 when co-founder Peter Scutt...
St Vincent's Health Australia is Australia's largest not-for-profit provider of health and aged care services, operating public and private hospitals, residential aged care, and community and virtual care programs.
MedHealth is a purpose-built collection of industry-leading health, medical, and employment brands that leverage diverse capabilities to deliver optimal health and employment outcomes for the people and communities they support.
MedHealth's Top Stability & Growth Strengths
Market Expansion: Active acquisitions and site growth are expanding national reach, with integrations across NDIS and allied health and operations spanning hundreds of locations. This pattern indicates continued scaling of footprint across Australia.
Strong Market Position & Advantage: Extensive scale across 300+ locations and thousands of professionals, combined with a portfolio of specialized brands, underpins a prominent position in integrated health and employment services. Alignment with ExamWorks’ international network further reinforces this standing.
Diversified Revenue Streams: Services span workplace health management, independent medical assessments, rehabilitation and return-to-work programs, employment services, NDIS support, and health technology. This breadth points to multiple income lines across both government and private sectors.
The Royal Australasian College of Surgeons (RACS) is a nonprofit professional body for surgeons in Australia and New Zealand. It trains and assesses surgical trainees, awards specialist qualifications, supports continuing professional development, and promotes high standards of surgical care, professionalism and education. RACS also advocates for surgical standards, represents the surgical fellowship, and provides public information about surgery and qualified...
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. At LivaNova, we understand the importance of bringing both clinical and economic value to...
LivaNova's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results indicate revenue rose at a double‑digit pace in 2025 and into early 2026, with management increasing full‑year growth guidance. Filings attribute momentum to broad strength across Cardiopulmonary and Neuromodulation.
Strong Market Position & Advantage: Evidence points to leadership in implantable VNS and a top‑tier position in cardiopulmonary perfusion, supported by a large installed base and competitor retrenchment. Independent coverage and recognition of pivotal studies reinforce defensible share within chosen niches.
Product Line Growth: Commercial uptake of the Essenz Perfusion System and steady consumables demand are driving cardiopulmonary expansion. Approval of the aura6000 device for obstructive sleep apnea and a connected‑care VNS roadmap add incremental growth avenues.
RSL LifeCare is an Australian social purpose organisation serving veterans, seniors and their families. It provides aged care through residential homes and personal home care, retirement living in villages, and veteran support services. Its integrated wellbeing and care approach operates across more than 60 sites in New South Wales and the Australian Capital Territory, with the stated purpose of enriching...
Halaxy makes healthcare better all over the world. Halaxy is a platform for patients, practitioners and people everywhere, and provides: 1. Practice management software (EMR, billing and scheduling) for any practitioner of any profession in any practice anywhere in the world; 2. Searchable practitioner directories covering 50% of the English speaking world enabling people to find the right practitioner for...
PolyNovo is a disruptive ASX 200 medical technology company. Its products simplify managing acute complex wounds, redefining healing with differentiated outcomes across many etiologies. After treating 62,000+ patients across 46 countries, the company is investing for growth via new products, indications and markets with a view to treat millions more. Our registered address is 2/320 Lorimer St, Port Melbourne, Victoria...
Lyrebird Health is an AI medical scribe that securely listens in the background throughout your consultation, then intelligently generates a note tailored to your style, ready to transfer into the medical record. We're on a mission to automate all non-patient-facing work so that doctors can spend more time with patients and less time on paperwork.
HotDoc is Australia's largest and most trusted patient engagement platform. We take pride in helping over 21,000 practitioners connect with more than 9 million patients. The HotDoc platform includes: online bookings, recalls, reminders, check-in, place in queue, online processing of repeat prescription requests, and Inform (a tool designed to encourage patients to take a more proactive interest in preventative health...
Lenexa Medical is an Australian-based MedTech company that has developed the LenexaCARE technology to empower clinicians to deliver targeted, long-term solutions for personalised pressure injury prevention and patient monitoring. Pressure injuries are mostly preventable, however affect millions of people globally each year whilst costing healthcare systems billions of dollars worldwide. In 2020, Australian public hospitals spent over $9 billion to...
